Merck Lowered Terns Pharmaceuticals Offer Price After Trial Data Review
Business

Merck Lowered Terns Pharmaceuticals Offer Price After Trial Data Review

April 7, 2026
Benzinga
Scroll

Merck cuts Terns deal price after TERN-701 data review, while maintaining interest amid competition and CML treatment comparisons. Importance Rank: 1 read more

Merck Lowered Terns Pharmaceuticals Offer Price After Trial Data Review
Read Full Article
Benzinga
Benzinga

Coverage and analysis from United States of America. All insights are generated by our AI narrative analysis engine.

United States of America
Bias: center
You might also like

Explore More